Phase II Trial of SMO/AKT/NF2 inhibitors in Progressive Meningioma’s with SMO/AKT/NFT2 Mutations. Coordinator’s Contact Info: Mayra/Lisandra 305-519-2147 MSMC ONLY
Progressive Meningiomas with SMO/AKT/NFT2 Mutations
Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylat-ion
A Phase II/III Randomized Trial of VELIPARIB or PLACEBO in combination with adjuvant TEMOZOLOMIDE in newly diagnosed Glioblastoma with MGMT promoter Hypermethyation. Coordinator’s Contact Info: Tresalynn 786-296-9310 MSMC ONLY